[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
In two patients with acute leukaemia, the development of progressive interstitial pulmonary fibrosis was observed following chemotherapy with BCNU, Cytoxan and Ara-C. The x-ray changes were accompanied by restrictive changes of pulmonary function and, later on, by severe hypoxia. Serologic tests did not reveal infection with cytomegaly virus or mycoplasma pneumoniae. These findings, together with reports in the literature, suggest a toxic effect of BCNU on the lung. The combination with Cyclophosphamide may contribute to this toxic reaction.
D000208:Acute Disease; D002330:Carmustine / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D003561:Cytarabine; D003520:Cyclophosphamide; D002330:Carmustine
Progrediente Lungenfibrose unter Kombinationstherapie mit BCNU.